Eintrag weiter verarbeiten
Aromatase Expression in the Hippocampus of AD Patients and 5xFAD Mice
Gespeichert in:
| Zeitschriftentitel: | Neural Plasticity |
|---|---|
| Personen und Körperschaften: | , , , , , |
| In: | Neural Plasticity, 2016, 2016, S. 1-11 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Hindawi Limited
|
| Schlagwörter: |
| Zusammenfassung: | <jats:p>Numerous studies show that 17<jats:italic>β</jats:italic>-estradiol (E<jats:sub>2</jats:sub>) protects against Alzheimer’s disease (AD) induced neurodegeneration. The E<jats:sub>2</jats:sub>-synthesizing enzyme aromatase is expressed in healthy hippocampi, but although the hippocampus is severely affected in AD, little is known about the expression of hippocampal aromatase in AD. To better understand the role of hippocampal aromatase in AD, we studied its expression in postmortem material from patients with AD and in a mouse model for AD (5xFAD mice). In human hippocampi, aromatase-immunoreactivity was observed in the vast majority of principal neurons and signal quantification revealed higher expression of aromatase protein in AD patients compared to age- and sex-matched controls. The tissue-specific first exons of aromatase I.f, PII, I.3, and I.6 were detected in hippocampi of controls and AD patients by RT-PCR. In contrast, 3-month-old, female 5xFAD mice showed lower expression of aromatase mRNA and protein (measured by qRT-PCR and semiquantitative immunohistochemistry) than WT controls; no such differences were observed in male mice. Our findings stress the importance of hippocampal aromatase expression in neurodegenerative diseases.</jats:p> |
|---|---|
| Umfang: | 1-11 |
| ISSN: |
2090-5904
1687-5443 |
| DOI: | 10.1155/2016/9802086 |